Rezon Bio is a European biologics CDMO headquartered in Poland, specializing in mammalian drug substance development and GMP manufacturing. The company operates two FDA-approved facilities with mirrored capabilities, employs approximately 1,300 people (10% PhDs), and has 16 years of biologics development experience. Rezon Bio offers end-to-end services from cell line development through commercial manufacturing with 2,000L bioreactors.
mammalian cell culture, biologics GMP manufacturing, upstream and downstream bioprocessing, tech transfer, process development and characterization
1 site worldwide
No reviews available yet.
No documents available.